Tag: Diabetes: Type II
Resistance Interval Training Improves Endothelial Function
R-INT improves flow-mediated dilation throughout two-hour post-exercise period in T2DM patients
Changes in Use of Glucose-Lowering Drugs From 2006-2013
Increase in metformin, DPP-4 inhibitors, insulin use; decrease in sulfonylureas and thiazolidinediones
T2DM Predicts Mortality in Patients With Heart Failure
Type 2 diabetes mellitus predicts mortality, regardless of presence of ischemic heart disease
Gliptin Treatment Tied to Higher Risk of Acute Pancreatitis
Data from three large trials show increased risk with saxagliptin, alogliptin, sitagliptin treatment
Insulin Glargine, Lixisenatide Combo Beneficial in T2DM
Improved achievement of glycemic targets, reduced body weight
CCTA Has Prognostic Value in Asymptomatic T2DM Patients
Excellent long-term prognoses for patients with normal coronary arteries, non-obstructive CAD
Quality of Diet Linked to Risk of T2DM Regardless of BMI Change
Association only partly explained by body weight changes
Gemigliptin, Metformin Combo Beats Monotherapy in T2DM
Greater change in HbA1c from baseline to 24 weeks with combination therapy versus monotherapies
IL-32 Has Inflammatory Properties in Human Obesity
Increased circulating IL-32 in obese patients down after Roux-en-Y gastric bypass-linked weight loss
Fatty Acid Consumption Tied to T2DM Risk in Women
Findings for arachidonic acid,
docosapentaenoic acid, and alpha-linolenic acid
